CSIMarket
 


Envista Holdings Corporation  (NVST)
Other Ticker:  
 
 

NVST's Revenue Growth by Quarter and Year

Envista Holdings's Revenue results by quarter and year




NVST Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 645.60 660.80 452.30
III Quarter September - 631.30 631.10 607.30
II Quarter June - 662.40 645.80 740.10
I Quarter March 623.30 627.20 631.40 709.20
FY   623.30 2,566.50 2,569.10 2,508.90



NVST Revenue first quarter 2024 Y/Y Growth Comment
Envista Holdings Corporation reported decrease in Revenue in the first quarter 2024 by -0.62% to $ 623.30 millions, from the same quarter in 2023.
The decrease in the first quarter 2024 Envista Holdings Corporation's Revenue compares unfavorably to the Company's average Revenue rise of 35.67%.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue growth. While Envista Holdings Corporation' s Revenue decline of -0.62% ranks overall at the positon no. 669 in the first quarter 2024.




NVST Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -2.3 % 46.1 % -38.24 %
III Quarter September - 0.03 % 3.92 % -5.18 %
II Quarter June - 2.57 % -12.74 % 104.45 %
I Quarter March -0.62 % -0.67 % -10.97 % 29.61 %
FY   - -0.1 % 2.4 % 9.94 %

Financial Statements
Envista Holdings's first quarter 2024 Revenue $ 623.30 millions NVST's Income Statement
Envista Holdings's first quarter 2023 Revenue $ 627.20 millions Quarterly NVST's Income Statement
New: More NVST's historic Revenue Growth >>


NVST Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 2.27 % 4.71 % -25.52 %
III Quarter September - -4.7 % -2.28 % -17.94 %
II Quarter June - 5.61 % 2.28 % 4.36 %
I Quarter March -3.45 % -5.08 % 39.6 % -3.15 %
FY (Year on Year)   - -0.1 % 2.4 % 9.94 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #79
Overall #669

Revenue Y/Y Growth Statistics
High Average Low
213.22 % 35.67 % -17.2 %
(Oct 01 2021)   (Jul 01 2022)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #79
Overall #669
Revenue Y/Y Growth Statistics
High Average Low
213.22 % 35.67 % -17.2 %
(Oct 01 2021)   (Jul 01 2022)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Envista Holdings's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
76.93 % 3.38 % -33.85 %
(Oct 02 2020)  


NVST's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Envista Holdings Corporation disclosed fall in Revenue from the previous quarter by -3.45% to $ 623.30 millions, from $ 645.60 millions declared in the previous reporting period.

If you evaluate recent slump at the I. Quarter, you must assume, that commonly I. Quarter performance occur softer relative to the preciding period, Jonathan Lewis, Medical Equipment & Supplies industry expert mentioned.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Envista Holdings's Revenue growth quarter on quarter, overall rank is 672.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #65
Overall #672
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #65
Overall #672
Revenue Q/Q Growth Statistics
High Average Low
76.93 % 3.38 % -33.85 %
(Oct 02 2020)  


NVST's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Envista Holdings Corporation disclosed fall in Revenue from the previous quarter by -3.45% to $ 623.30 millions, from $ 645.60 millions achived in the previous reporting period.

This is not big problem, as Revenue always tend to plunge in the I. Quarter.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Envista Holdings's Revenue growth quarter on quarter, overall rank is 672.


Envista Holdings's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 29 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 29 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 2,562.60 $ 2,566.50 $ 2,581.70 $ 2,581.50 $ 2,564.90
Y / Y Revenue Growth (TTM) -0.09 % -0.1 % 9.37 % 10.47 % 5.5 %
Year on Year Revenue Growth Overall Ranking # 465 # 448 # 3021 # 1989 # 2442
Seqeuential Revenue Change (TTM) -0.15 % -0.59 % 0.01 % 0.65 % -0.16 %
Seq. Revenue Growth (TTM) Overall Ranking # 669 # 288 # 469 # 1704 # 2729




Cumulative Revenue growth Comment
Envista Holdings showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2023. If the fiscal year would end in Mar 29 2024, Envista Holdings's annual Revenue decline would be -0.09% year on year to $2,563 millions.

In the Healthcare sector 66 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 448 to 465.

Revenue TTM Q/Q Growth Statistics
High Average Low
213.22 %
35.67 %
-17.2 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 67
Overall # 465

Revenue TTM Y/Y Growth Statistics
High Average Low
213.22 %
35.67 %
-17.2 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 79
S&P 500 # 669
Cumulative Revenue growth Comment
Envista Holdings showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2023. If the fiscal year would end in Mar 29 2024, Envista Holdings's annual Revenue fall would be -0.09% year on year to $2,563 millions.

In the Healthcare sector 66 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 448 to 465.

Revenue TTM Q/Q Growth Statistics
High Average Low
213.22 %
35.67 %
-17.2 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 67
Overall # 465

Revenue TTM Y/Y Growth Statistics
High Average Low
213.22 %
35.67 %
-17.2 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 79
S&P 500 # 669




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVST's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NVST's Competitors
Revenue Growth for Envista Holdings's Suppliers
Revenue Growth for NVST's Customers

You may also want to know
NVST's Annual Growth Rates NVST's Profitability Ratios NVST's Asset Turnover Ratio NVST's Dividend Growth
NVST's Roe NVST's Valuation Ratios NVST's Financial Strength Ratios NVST's Dividend Payout Ratio
NVST's Roa NVST's Inventory Turnover Ratio NVST's Growth Rates NVST's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 29 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 29 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc -0.70%$ -0.704 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Ocuphire Pharma Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions
Elanco Animal Health Inc-4.14%$ -4.137 millions
Ptc Therapeutics inc -4.66%$ -4.657 millions
Foghorn Therapeutics Inc -4.88%$ -4.879 millions
Aclaris Therapeutics Inc -5.14%$ -5.142 millions
Avantor Inc -5.65%$ -5.645 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com